Rachel Reynolds: Spotting Head & Neck Skin Cancer

Skin cancer is the most common malignancy worldwide, and the head and neck region accounts for the majority of cases encountered in clinical practice. Early recognition can dramatically improve outcomes, yet potentially dangerous lesions are often overlooked or mistaken for benign conditions.

In this practical, case-based lecture, Dr. Rachel Reynolds will provide clinicians with a systematic approach to identifying common and high-risk skin cancers of the head and neck. Through clinical photographs and real-world examples, participants will learn how to distinguish benign lesions from basal cell carcinoma, squamous cell carcinoma, melanoma, and other cutaneous malignancies that warrant urgent evaluation.

The session will focus on visual recognition, risk assessment, biopsy considerations, referral pathways, and the surgeon's role in early diagnosis. Particular attention will be paid to lesions that commonly present to oral and maxillofacial surgeons, head and neck surgeons, dermatologists, plastic surgeons, and primary care providers.

Whether you are a trainee or an experienced clinician, this lecture will enhance your ability to recognize potentially life-threatening skin cancers before they are missed.

SPEAKER

Rachel V. Reynolds, MD, is Interim Chair of Dermatology at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School. She completed medical school at the University of Pennsylvania and her dermatology residency through the Harvard Combined Dermatology Program. She practices medical, surgical, and cosmetic dermatology and is recognized nationally for her clinical and educational contributions.

Dr. Reynolds serves in numerous leadership roles within the American Academy of Dermatology and has contributed to national clinical guidelines and educational initiatives. In addition to her expertise in general and surgical dermatology, she has a particular interest in skin cancer detection and the care of high-risk patients.

Her lecture will focus on the practical recognition of head and neck skin cancers and the diagnostic clues that help clinicians identify lesions requiring further investigation and treatment.

Professional Websites

Harvard Health Publishing: https://www.health.harvard.edu/authors/rachel-reynolds-md

Beth Israel Deaconess Medical Center: https://findadoc.bidmc.org/details/1267/rachel-reynolds-dermatology-boston-chestnut_hill-needham

Harvard Catalyst Faculty Profile: https://connects.catalyst.harvard.edu/profiles/display/Person/87938

Google Scholar: https://scholar.google.com/citations?user=uHcJsrcAAAAJ

ResearchGate: https://www.researchgate.net/profile/Rachel-Reynolds-4

LEARNING OBJECTIVES

By the end of this event, participants will be able to:

1. Recognize the clinical features of common head and neck skin cancers.

2. Differentiate benign lesions from malignant and premalignant conditions.

3. Identify high-risk features requiring urgent biopsy or referral.

4. Understand the role of imaging, pathology, and multidisciplinary care.

5. Improve early detection and patient outcomes through systematic evaluation.

TARGET AUDIENCE

• Oral and Maxillofacial Surgeons

• Head & Neck Surgeons

• Dermatologists

• Plastic Surgeons

• ENT Surgeons

• Residents and Fellows

• Medical and Dental Students

• Primary Care Providers

FREE ONLINE LIVE EVENT

San Francisco: Monday, September 14, 2026 at 4:00 pm

Mexico City: Monday, September 14, 2026 at 5:00 pm

New York: Monday, September 14, 2026 at 7:00 pm

Rio de Janeiro: Monday, September 14, 2026 at 8:00 pm

London: Tuesday, September 15, 2026 at 12:00 midnight

Berlin: Tuesday, September 15, 2026 at 1:00 am

Johannesburg: Tuesday, September 15, 2026 at 1:00 am

Cairo: Tuesday, September 15, 2026 at 2:00 am

Dubai: Tuesday, September 15, 2026 at 3:00 am

Delhi: Tuesday, September 15, 2026 at 4:30 am

Manila: Tuesday, September 15, 2026 at 7:00 am

Sydney: Tuesday, September 15, 2026 at 9:00 am

LANGUAGE: The event language is English.

CE ACCREDITATION : surgeON is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. surgeON designates this activity for 1 credit hour of continuing education credits.

DECLARATION

In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.